CIK 0001817241 · <br>Emerging growth company
Artiva Biotherapeutics, Inc.
Sign in to watch- Ticker
- ARTV
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 863614316
- Phone
- (858) 267-4467
- Business address
- 5505 MOREHOUSE DRIVE, SAN DIEGO, CA, 92121
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,341,159
- in 16 filings, $529K under 10b5-1 plans
Net −$2,341,159. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-12 | Bush Jennifer COO, CLO, Secy, Compliance Off | Returned to the company · Employee Stock Option (Right to Buy) | −9,119 | 0 | ||
| 2025-12-12 | Bush Jennifer COO, CLO, Secy, Compliance Off | Returned to the company · Employee Stock Option (Right to Buy) | −14,202 | 0 | ||
| 2025-12-12 | Bush Jennifer COO, CLO, Secy, Compliance Off | Returned to the company · Employee Stock Option (Right to Buy) | −20,519 | 0 | ||
| 2025-12-12 | Aslan Fred President and CEO | Grant or award | +869,136 | 1,213,135 | ||
| 2025-12-12 | Aslan Fred President and CEO | Returned to the company · Employee Stock Option (Right to Buy) | −100,577 | 0 | ||
| 2025-12-12 | Aslan Fred President and CEO | Returned to the company · Employee Stock Option (Right to Buy) | −51,463 | 0 | ||
| 2025-12-12 | Aslan Fred President and CEO | Returned to the company · Employee Stock Option (Right to Buy) | −257,319 | 0 | ||
| 2025-12-12 | Aslan Fred President and CEO | Returned to the company · Employee Stock Option (Right to Buy) | −26,450 | 0 | ||
| 2025-12-12 | Aslan Fred President and CEO | Returned to the company · Employee Stock Option (Right to Buy) | −113,999 | 0 | ||
| 2025-12-12 | Aslan Fred President and CEO | Returned to the company · Employee Stock Option (Right to Buy) | −319,331 | 0 | ||
| 2025-11-17 | Aslan Fred President and CEO | Sale 10b5-1 | −6,375 | $3.38 | $22K | 343,999 |
| 2025-11-15 | Raymon Heather SVP, Research and Development | Shares withheld for taxes | −1,375 | $3.25 | $4K | 39,591 |
| 2025-11-15 | Horan Christopher Chief Tech Operations Officer | Shares withheld for taxes | −1,899 | $3.25 | $6K | 78,183 |
| 2025-11-15 | Bush Jennifer COO, CLO, Secy, Compliance Off | Shares withheld for taxes | −3,055 | $3.25 | $10K | 148,048 |
| 2025-11-15 | Krishnamohan Neha Chief Financial Officer | Shares withheld for taxes | −3,490 | $3.25 | $11K | 99,356 |
| 2025-11-15 | Aslan Fred President and CEO | Shares withheld for taxes 10b5-1 | −6,347 | $3.25 | $21K | 350,374 |
| 2025-10-17 | Aslan Fred President and CEO | Sale 10b5-1 | −25,500 | $6.00 | $153K | 356,721 |
| 2025-08-15 | Aslan Fred President and CEO | Sale 10b5-1 | −25,500 | $2.73 | $70K | 386,693 |
| 2025-08-15 | Aslan Fred President and CEO | Shares withheld for taxes 10b5-1 | −4,472 | $2.75 | $12K | 382,221 |
| 2025-08-15 | Raymon Heather SVP, Research and Development | Shares withheld for taxes | −1,639 | $2.75 | $5K | 40,966 |
Page 6 of 11 · 203 trades